PSI vs Worldwide Clinical Trials

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/appian/worldwide

Category	PSI	Worldwide Clinical Trials
Listed site	cro	cro
Summary	PSI runs full-service Phase 2 and 3 clinical trials with a stated focus on on-time enrollment and over 90% repeat and referral business. Key therapeutic areas include oncology, GI, hematology, cell and gene therapy, neurology, and infectious diseases.	Full-service global CRO with 30+ years of therapeutic expertise, delivering personalized clinical trial support across rare disease, cardiovascular, cell & gene therapy, oncology, and neuroscience.
Services	Phase II Clinical Trials Phase III Clinical Trials Clinical Operations	Phase I Clinical Trials Phase II Clinical Trials Phase III Clinical Trials Phase IV / Post-Marketing Clinical Operations Biostatistics & Statistical Programming Data Management & eClinical Medical Writing Bioanalysis Pharmacovigilance & Drug Safety Regulatory Affairs Cardiovascular & Metabolic Specialty Services Oncology Specialty Services CNS Specialty Services Immunology & Inflammation Services Clinical Trial Services
Modalities	Cell Therapy Gene Therapy Radiopharmaceutical	Antibody-Drug Conjugate (ADC) Cell Therapy Gene Therapy
Indications	Oncology Gastroenterology Neurology Infectious Disease Respiratory Immunology Cardiovascular Nephrology Metabolic	Oncology Neurology Psychiatry Cardiovascular Metabolic Respiratory Rare Disease Immunology
Locations	Osaka, Osaka, Osaka, Japan	Data not yet provided.
Certifications	Data not yet provided.	Data not yet provided.
Reviews	Review summary appears after site-level review signal gate opens.	Review summary appears after site-level review signal gate opens.